By exploring how NTZ modulates key pathways like STAT-3 and NF-κB across different models, researchers can gain valuable insights into its mechanism of action, potentially leading to more targeted and effective treatments for RA. The gene discussed is STAT3; the disease is rheumatoid arthritis.